Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Experts say the ACR/AAHKS 2022 guidelines for patients undergoing total hip replacement or total knee replacement have several limitations that limit the effectiveness of their recommendations.
Read Full NewsClinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.
Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.
Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.
The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
It Is Not Just the Royals Who Go Through Cancer.
3.
African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis
4.
Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.
5.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
1.
The Latest Advances in Glioblastoma Treatment and Prevention
2.
Ultimate Guide to Oncology Services in the USA
3.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
4.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
5.
Revolutionizing Cancer Care with Fulphila: A New Hope for Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge